Enhanced liver cell mutations in trematode-infected Big Blue® transgenic mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 355-360

  Gentile, James M ^a   Gentile, Glenda J ^a   Nannenga, Bonnie ^a   Johnson, Michelle ^a   Blankespoor, Harvey ^a   Montera, Regina ^b  

^a HOPE COLLEGE   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Big Blue; Fasciola; Hepatic; Mutation; Transgenic

Indexed keywords

ANIMAL MODEL; ARTICLE; BLADDER CANCER; FASCIOLA HEPATICA; GENE MUTATION; HELICOBACTER PYLORI; HEPATITIS B VIRUS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OPISTHORCHIS VIVERRINI; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; STOMACH CANCER; TRANSGENIC MOUSE; TREMATODIASIS;

ANIMALS; BACTERIAL PROTEINS; COLIPHAGES; DNA MUTATIONAL ANALYSIS; DNA, HELMINTH; ESCHERICHIA COLI PROTEINS; FASCIOLA HEPATICA; FASCIOLIASIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; REPRESSOR PROTEINS; TRANSGENES;

EID: 0032565579     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00049-9     Document Type: Article

References (30)

1. [1] M.F. Bassendine, Aetiological factors in hepatocellular cancer, Bailliere's Clin. Gastroenterol. 1 (1987) 1-16.
2. 1 metabolism in Hepatitis B virus transgenic mice, Mol. Carcinogen. 11 (1994) 74-80.
3. 1 by hamster liver CYP2A enzymes, Chem. Biol. Interact. 93 (1994) 41-50.
4. [4] F.J. Johnson, Chemical interactions with herpes simplex type 2 virus: enhancement of transformation by selected carcinogens and procarcinogens, Carcinogenesis 3 (1982) 1235-1240.
5. [5] F. Campanile, A.M. Iorio, E. Bonmassar, Natural resistance of mice pretreated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carbocamide (DTIC) and cyclophosphamide (Cy) against virus-induced lymphoma cells, Int. J. Immunopharmacol. 6 (1984) 251-258.
6. [6] R.W. Engleman, N.K. Day, R.A. Good, Calories and cell proliferation, and proviral expression in autoimmunity and cancer, P.S.E.B.M. 203 (1993) 13-17.
7. [7] WHO/IARC, IARC Monograph on the evaluation of carcinogenic risks to humans, Schistosomes, Liver flukes and Helicobacter pylori, Vol. 61, Lyon, 1994.
8. [8] J.M. Gentile, Schistosome-related cancers: a possible role for genotoxins, Environ. Mol. Mutagen. 7 (1985) 775-785.
9. [9] P.G.N. Kramers, J.M. Gentile, B.J.A.M. Gryseels, P. Jordan, N. Katz, K.E. Mott, J.J. Mulvihill, J.L. Seed, H. Frohberg, Review of the genotoxicity and carcinogenicity of antischistosomal drugs: is there a case for a study of mutation epidemiology?, Mutation Res. 257 (1991) 49-89.
10. [10] M.P. Rosin, S. Saad El Din Zaki, A.J. Ward, W.A. Anwar, Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients, Mutation Res. 305 (1994) 283-292.
11. [11] J.M. Gentile, G.J. Gentile, Implications for the involvement of the immune system in parasite-associated cancers, Mutation Res. 305 (1994) 315-320.
12. [12] M.R. Haswell-Elkins, S. Satarug, D.B. Elkins, Opisthorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma, J. Gastroenterol. Hepatol. 7 (1992) 538-548.
13. [13] H. Ohshima, H. Bartsch, Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis, Mutation Res. 305 (1994) 283-292.
14. [14] G.M. Kirby, P. Pelkonen, V. Vatanasapt, A.M. Camus, C.P. Wild, M. Lang, Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver, Mol. Carcinogen. 11 (1994) 81-89.
15. [15] D. Blair, Molecular variation in fasciolids and Paragonimus, Acta Trop. 53 (1993) 277-289.
16. 1 in male Holstein calves with prior infection by flukes (Fasciola hepatica), Am. J. Vet. Res. 38 (1977) 341-349.
17. 1, Toxicol. Lett. 8 (1981) 273-282.
18. [18] Stratagene, Big Blue® transgenic mouse assay system: instructional manual, La Jolla, CA, 1992.
19. [19] http://darwin.ceh.uvic.ca/bigblue/bigblue.htm.
20. [20] S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, J.A. Sorge, D.L. Putman, J.M. Short, Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7958-7962.
21. [21] R.V. Hogg, E.A. Tanis, Probability and Statistical Inference, 4th edn., MacMillan, New York, 1993, 732 pp.
22. [22] S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, D.L. Putman, J.A. Sorge, J.M. Short, Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector, Environ. Mol. Mutagen. 18 (1991) 316-321.
23. [23] J.-H. Lee, H.-J. Rimand, U.-B. Bak, Effect of Clonorchis sinensis infection and dimethylnitrosamine administration on the induction of cholangiocarcinoma in Syrain golden hamsters, Korean J. Parasitol. 31 (1993) 21-30.
24. [24] E. Vandewaa, C.C. Barney, J.M. Gentile, Promutagen activation in partially hepatectomized mice, Toxicol. Lett. 14 (1982) 253-260.
25. [25] B.S. Shane, A.-M.C. Lockhart, G.W. Winston, K.R. Tindall, Mutant frequencey of lad in transgenic mice following benzy[a]pyrene treatment and partial hepatectomy, Mutation Res., 1997, 1-11.
26. 1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone, Mutagenesis 11 (1997) 69-73.
27. [27] T.F. Tracey, A.J. Tector, M.E. Goerke, S. Kitchen, D. Lagunoff, Somatostatin analogue (Octretide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction, Am. J. Pathol. 143 (1993) 1574-1578.
28. [28] R. Montera, G.J. Gentile, L. Frederick, J. McMannis, T. Murphey, H. Blankespoor, J.M. Gentile, Induced expression of CYP2A5 in inflamed trematode-infested mouse liver, Int. J. Cancer, 1998, submitted.
29. [29] P. Pellinen, F. Stenbäck, A. Rautio, O. Pelkonen, M. Lang, M. Fasanen, Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases, Arch. Pharmacol. 348 (1993) 435-443.
30. [30] H. Tsuda, S. Satarug, V. Bhudhisawasdi, T. Kihana, T. Sugimura, S. Hirohashi, Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene, Mol. Carcinogen. 6 (1992) 266-269.